Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: J.S. who wrote (2257)	2/13/2008 11:12:38 AM
From: Jibacoa	Respond to of 3722

I don't get it why the stock price is so low. It seems the stock price was affected by the sale of common & warrants on Dec, as well as the larger loss on the 2ndQ. As mentioned, the Jade subsidiary's valuation of its land use rights, & its plant and buildings have been reappraised for $21.8M, which is significantly > the FY2007 book value of those assets. ADL has 4 Qs of significant improvement on revenues & the earnings on the 3rdQ were on the black for the 1st time. <g> It seems the pending 4thQ results should also be good by comparison, since in 2006 it had a loss 0f $0.45/shr, much larger than the $0.12/shr in 2005, when revenues were 0.01% of the 2006 revenues. The insiders reportedly hold > 20% & the short ratio is around 5x its ADV If the 4thQ results come out good, it seems the stock could have a nice spike to the $4.20 level, which would be a 40% gain from present levels.<g> bigcharts.marketwatch.com Bernard